申请人:Janssen Pharmaceutica NV
公开号:US08912227B1
公开(公告)日:2014-12-16
The present invention is directed to bicyclic pyrrole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by GPR120. More particularly, the compounds of the present invention are agonists of GPR120, useful in the treatment of, such as for example, Type II diabetes mellitus.
本发明涉及双环吡咯衍生物、含有它们的药物组合物以及它们在治疗通过GPR120调节的疾病和状况中的用途。更具体地说,本发明的化合物是GPR120的激动剂,可用于治疗诸如2型糖尿病等疾病。